WallStreetZenWallStreetZen

NASDAQ: BCYC
Bicycle Therapeutics PLC Stock Ownership - Who owns Bicycle Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Bicycle Therapeutics PLC insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Michael Charles Ferguson HannayCHIEF PROD SUPPLY CHAIN OFF2025-10-03250$8.41
$2.10kSell
Travis Alvin ThompsonCHIEF ACCOUNTING OFFICER2025-10-03103$8.41
$866.23Sell
Michael SkynnerCHIEF TECHNOLOGY OFFICER2025-10-03978$8.41
$8.22kSell
Alistair MilnesCHIEF OPERATING OFFICER2025-10-03978$8.41
$8.22kSell
Kevin LeeCHIEF EXECUTIVE OFFICER2025-10-033,231$8.41
$27.17kSell
Robert Charles SwantonDirector2025-10-02102$8.55
$872.10Sell
Alethia YoungChief Financial Officer2025-10-02265$8.61
$2.28kSell
Michael SkynnerCHIEF TECHNOLOGY OFFICER2025-10-02824$8.40
$6.92kSell
Michael Charles Ferguson HannayCHIEF PROD SUPPLY CHAIN OFF2025-10-02473$8.40
$3.97kSell
Kevin LeeCHIEF EXECUTIVE OFFICER2025-10-022,263$8.40
$19.01kSell

1 of 6

BCYC insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when BCYC insiders and whales buy or sell their stock.

BCYC Shareholders

What type of owners hold Bicycle Therapeutics PLC stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Baker Bros Advisors LP15.69%10,885,357$80.88MInstitution
Baker Bros Advisors LP14.42%9,999,674$74.30MInsider
Fcpm III Services Bv4.98%3,452,330$25.65MInstitution
Armistice Capital LLC4.29%2,978,000$22.13MInstitution
Westfield Capital Management Co LP4.26%2,952,543$21.94MInstitution
Siren LLC2.90%2,012,752$14.95MInstitution
Carolyn Ng2.88%1,998,580$14.85MInsider
Tybourne Capital Management Hk Ltd2.82%1,957,961$14.55MInsider
Deborah Harland2.76%1,915,275$14.23MInsider
Svlsf V LLC2.76%1,915,274$14.23MInsider

1 of 3

BCYC vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BCYC53.19%43.20%Net BuyingNet Selling
NAGE18.41%81.59%Net BuyingNet Buying
ADCT54.76%34.45%Net BuyingNet Selling
MNPR18.47%81.53%Net SellingNet Selling
DSGN45.88%54.12%Net Selling
View Top Biotech Stocks

Bicycle Therapeutics Stock Ownership FAQ

Who owns Bicycle Therapeutics?

Bicycle Therapeutics (NASDAQ: BCYC) is owned by 53.19% institutional shareholders, 43.20% Bicycle Therapeutics insiders, and 3.62% retail investors. Baker Bros Advisors LP is the largest individual Bicycle Therapeutics shareholder, owning 10.00M shares representing 14.42% of the company. Baker Bros Advisors LP's Bicycle Therapeutics shares are currently valued at $74.50M.

If you're new to stock investing, here's how to buy Bicycle Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.